Funded Tech Companies

InVasic Therapeutics

Researching who provided funding to InVasic Therapeutics? Private investors joined the equity holders in this biopharmaceutical company.

Company Overview

Company Name
InVasic Therapeutics
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
2635 Walnut St.
Denver, CO 80205
USA
Email Address

Company Background Information

Overview
InVasc is a clinical stage biopharmaceutical company developing drugs to treat or prevent cardiometabolic disease. We are currently focused on advancing our two lead drugs for Chronic Kidney Disease and Atherosclerosis.
Profile
InVasic Therapeutics LinkedIn Company Profile
Social Media
InVasic Therapeutics Company Twitter Account
Company News
InVasic Therapeutics News
Facebook
InVasic Therapeutics on Facebook
YouTube
InVasic Therapeutics on YouTube
Last Transaction
7/9/2010

Financing History

Date
Type
Amount
Venture Equity
$3,150,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
William Johnston
  William Johnston LinkedIn Profile  William Johnston Twitter Account  William Johnston News  William Johnston on Facebook
Chief Operating Officer
William Schaeffer
  William Schaeffer LinkedIn Profile  William Schaeffer Twitter Account  William Schaeffer News  William Schaeffer on Facebook


Company Investors

     

     

     

    Browse more funded tech companies:

    Invary | Inven

     

    Share this article

     


    About Our Venture Capital Database

    The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.

     


    Additional Resources for Entrepreneurs

    Lists of Venture Capital and Private Equity Firms

    Franchise Opportunities

    Contributors

    Business Glossary